Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Garcia-Vicuna R 

PROVIDER: S-EPMC7480631 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature